Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes
Journal of Pharmacology and Experimental Therapeutics, 10/26/09
Onali P et al. – The results demonstrate that TCAs differentially regulate opioid receptors with a preferential agonist activity on either or subtypes and suggest that this property may contribute to their therapeutic and/or side effects.
Related Articles
Glutamate-based antidepressants: 20 years on
Trends in Pharmacological Sciences, 10/29/09
Relevance Score: 66%
Synaptic Adaptations of CA1 Pyramidal Neurons Induced by a Highly Effective Combinational Antidepressant Therapy
Biological Psychiatry, 11/18/09
Relevance Score: 65%
The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets, 10/30/09
Relevance Score: 64%
Early induction of CREB activation and CREB-regulating signalling by antidepressants
International Journal of Neuropsychopharmacology, 10/21/09
Relevance Score: 64%
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Expert Opinion on Investigational Drugs, 10/02/09
Relevance Score: 64%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
Current Drug Targets, 03/22/10
Acute Stress Impairs Hippocampal Mossy Fiber-CA3 Long-Term Potentiation by Enhancing cAMP-Specific Phosphodiesterase 4 Activity
Neuropsychopharmacology, 03/19/10
Long circulating nanoparticles of etoposide using PLGA-MPEG and PLGA-pluronic block copolymers: characterization, drug-release, blood-clearance, and biodistribution studies
Drug Development Research, 03/18/10
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
(gamma)-Secretase as a Therapeutic Target in Alzheimer's Disease
Current Drug Targets, 03/22/10
Cannabinoids, Opioids and MDMA: Neuropsychological Interactions Related to Addiction
Current Drug Targets, 03/22/10
Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic-Induced Weight Gain
Annals of Pharmacotherapy, 03/22/10
Article Search
Sponsor
Sponsor


See Latest Articles


